semaglutide bottle says not for human consumption Mix-it-yourself Wegovy? Some try risky sources obesity drugs Some people are overdosing on

WHAT IS THE KLOW PEPTIDE PROTOCOL

Mechanism of Action and Weight Loss Outcomes in Non-Diabetics GLP-1 agonists work by stimulating glucagon-like peptide-1 receptors in the brain and gut, reducing appetite and increasing satiety

Yamines Alifonso, MD on July 31, 2026

Jarvelainen, H

Common FDA-approved GLP-1 medications include: Originally developed for people with type 2 diabetes, these medications have been increasingly prescribed for chronic weight management, particularly for those with obesity or weight-related health conditions

GLP-1 patches are a wellness supplement and are not a substitute for any prescribed medication, including those for diabetes or other conditions